CDKN2A might be better than telomere length in determining individual health status

BMJ (Online)

Volumn 344, Issue 7847, 2012, Pages

  Shiels, Paul G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGE; AGING; CDKN2A GENE; EPIGENETICS; GENE; GENE EXPRESSION; HEALTH STATUS; HUMAN; LETTER; LIFESTYLE; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIOECONOMICS; TELOMERE; TELOMERE LENGTH; GENETIC SCREENING; GENETICS; METHODOLOGY; NOTE;

AGING; GENETIC TESTING; HUMANS; TELOMERE;

EID: 84858048696     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e1415     Document Type: Letter

References (6)

1. McCartney M. Would you like your telomeres tested? BMJ 2012;344:e681. (8 February.)
2. Baker GT 3rd, Sprott RL. Biomarkers of aging. Exp Gerontol 1988;23:223-39.
3. Koppelstaetter C, Schratzberger G, Perco P, Hofer J, Mark W, Ollinger R, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell 2008;7:491-7. (Pubitemid 351998609)
4. McGlynn LM, Stevenson K, Lamb K, Zino S, Brown M, Prina A, et al. Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell 2009;8:45-51.
5. Shiels PG. Improving precision in investigating aging: why telomeres can cause problems. J Gerontol A Biol Sci Med Sci 2010;65:789-91.
6. Shiels PG, McGlynn LM, MacIntyre A, Johnson PC, Batty GD, Burns H, et al. Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS One 2011;6:e22521.